OTCMKTS:MYDP

Dougherty's Pharmacy Stock Forecast, Price & News

$0.02
0.00 (0.00 %)
(As of 03/15/2021)
Add
Compare
Today's Range
$0.02
$0.02
50-Day Range
$0.02
$0.02
52-Week Range
$0.00
$0.02
Volume9,000 shs
Average Volume9,011 shs
Market Capitalization$346,470.00
P/E RatioN/A
Dividend YieldN/A
Beta3.68
30 days | 90 days | 365 days | Advanced Chart
Receive MYDP News and Ratings via Email

Sign-up to receive the latest news and ratings for Dougherty's Pharmacy and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Drug stores & proprietary stores
Sub-IndustryN/A
SectorMedical
Current SymbolOTCMKTS:MYDP
CUSIPN/A
Phone972-250-0945
Employees75
Year FoundedN/A

Sales & Book Value

Annual Sales$36.05 million

Profitability

Debt

Price-To-Earnings

Miscellaneous

Market Cap$346,470.00
Next Earnings DateN/A
OptionableNot Optionable

Headlines

See More Headlines

About Dougherty's Pharmacy

Dougherty's Pharmacy, Inc. focuses on acquiring, managing, and growing community based pharmacies in the Southwest Region of the United States. Its flagship store is Dougherty's Pharmacy, a turn-key multi-service pharmacy located in Dallas, Texas. The company was formerly known as Ascendant Solutions, Inc. and changed its name to Dougherty's Pharmacy, Inc. in May 2017. Dougherty's Pharmacy, Inc. was founded in 1929 and is based in Dallas, Texas.

MarketRank

Overall MarketRank

0.46 out of 5 stars

Medical Sector

1671st out of 2,042 stocks

Drug Stores & Proprietary Stores Industry

10th out of 14 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Dougherty's Pharmacy (OTCMKTS:MYDP) Frequently Asked Questions

What stocks does MarketBeat like better than Dougherty's Pharmacy?

Wall Street analysts have given Dougherty's Pharmacy a "N/A" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Dougherty's Pharmacy wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

How were Dougherty's Pharmacy's earnings last quarter?

Dougherty's Pharmacy, Inc. (OTCMKTS:MYDP) released its quarterly earnings data on Tuesday, August, 14th. The company reported ($0.02) earnings per share (EPS) for the quarter. The company had revenue of $9.17 million for the quarter.
View Dougherty's Pharmacy's earnings history
.

How has Dougherty's Pharmacy's stock price been impacted by COVID-19 (Coronavirus)?

Dougherty's Pharmacy's stock was trading at $0.01 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, MYDP stock has increased by 50.0% and is now trading at $0.0150.
View which stocks have been most impacted by COVID-19
.

Who are Dougherty's Pharmacy's key executives?

Dougherty's Pharmacy's management team includes the following people:
  • Mr. James C. Leslie CPA, CPA, Chairman, Interim Pres & CFO (Age 66, Pay $100k)
  • Mr. Stewart I. Edington, Chief Exec. Officer (Age 52)
  • Ms. Katherine Burrow, Managing Director of Bus. Devel.
  • Ms. Susan K. Olson, Sec.
  • Ms. Robin Bruce, Controller
  • Mr. Rick Troberman, Exec. VP of Sales and Marketing

Who are some of Dougherty's Pharmacy's key competitors?

What other stocks do shareholders of Dougherty's Pharmacy own?

What is Dougherty's Pharmacy's stock symbol?

Dougherty's Pharmacy trades on the OTCMKTS under the ticker symbol "MYDP."

How do I buy shares of Dougherty's Pharmacy?

Shares of MYDP can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Dougherty's Pharmacy's stock price today?

One share of MYDP stock can currently be purchased for approximately $0.02.

How much money does Dougherty's Pharmacy make?

Dougherty's Pharmacy has a market capitalization of $346,470.00 and generates $36.05 million in revenue each year.

How many employees does Dougherty's Pharmacy have?

Dougherty's Pharmacy employs 75 workers across the globe.

What is Dougherty's Pharmacy's official website?

The official website for Dougherty's Pharmacy is www.doughertys.com.

Where are Dougherty's Pharmacy's headquarters?

Dougherty's Pharmacy is headquartered at 5924 ROYAL LANE SUITE 250, DALLAS TX, 75230.

How can I contact Dougherty's Pharmacy?

Dougherty's Pharmacy's mailing address is 5924 ROYAL LANE SUITE 250, DALLAS TX, 75230. The company can be reached via phone at 972-250-0945 or via email at [email protected]


This page was last updated on 5/9/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.